BluMaiden Biosciences is a biotech therapeutics company operating in the USA and Europe. It leverages naturally occurring, human-derived small molecules to develop superior therapeutic solutions. Through its advanced computational platform, BluMaiden explores untapped chemical spaces within the human body, uncovering safer and biocompatible small molecule drug candidates. This innovative approach overcomes the limitations of traditional synthetic chemistry, driving groundbreaking treatments and transforming pharmaceutical drug pipelines.
Company Details
- Employees
- 11
- Founded
- -
- Address
- 16 Ayer Rajah Crescent, #05-03,singapore
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.blumaiden.com
- Keywords
- Biotechnology, Machine Learning, Drug Discovery, Computational Biology, Microbiome, Digital Healthcare, Artificial Intelligence, Clinical Trials, Computational Chemistry, Metagenomics, Inflammatory Disease, Oncology, Therapy Response Prediction, Patient Stratification, Surrogate End-points, Pharma Services, Pharma.
- HQ
- Singapore
Blumaiden Biosciences Questions
Blumaiden Biosciences's website is http://www.blumaiden.com
Blumaiden Biosciences's LinkedIn profile is https://sg.linkedin.com/company/blumaidenbiosciences
Blumaiden Biosciences has
11 employees.
View email and phone details for 11
employees at Blumaiden Biosciences.
Blumaiden Biosciences's industry is
Biotechnology Research
Blumaiden Biosciences's top competitors are
Seppure Technologies,
Nexcalibur Therapeutics,
Chemt Biotechnology,
Mesh Bio,
Hicura Medical Pte Ltd,
Angsana Investments Private Limited,
Otter Bio,
Singzyme,
Nalagenetics,
Betalife.
Blumaiden Biosciences's categories are Biotechnology Research
Blumaiden Biosciences's founding year is 2020
